Efficacy, safety and tolerability of escitalopram in doses up to 50 mg in Major Depressive Disorder (MDD): an open-label, pilot study

BACKGROUND: Escitalopram is licensed for use at doses up to 20 mg but is used clinically at higher doses. There is limited published data at higher doses and none in the treatment of Major Depressive Disorder (MDD). METHODS: This open-label, pilot study was designed to investigate the efficacy, safe...

Descripción completa

Detalles Bibliográficos
Autores principales: Wade, Alan G, Crawford, Gordon M, Yellowlees, Ann
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3068950/
https://www.ncbi.nlm.nih.gov/pubmed/21410960
http://dx.doi.org/10.1186/1471-244X-11-42

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3068950/
https://www.ncbi.nlm.nih.gov/pubmed/21410960
http://dx.doi.org/10.1186/1471-244X-11-42

Ejemplares similares